Vancomycin-based tracers guiding in situ visualization of bacteria on osteosynthesis devices and surgical debridement.

Spoelstra, Gerbren B; Elsinga, Philip H; van Dijl, Jan Maarten; van Snick, Johannes H; Feringa, Ben L; Glaudemans, Andor W J M; Keizers, Bas; Kruijff, Schelto et al. · Eur J Nucl Med Mol Imaging · 2025

basic_science · Level V

Where this comes from

Abstract

Bacterial infections associated with musculoskeletal injuries are challenging to detect and distinguish from sterile inflammation. Here we present the combined first-time application of a bacteria-targeted positron emission tomography (PET) tracer and a near-infrared fluorescent tracer to detect infected osteosynthesis implants and guide surgical treatment. To this end, osteosynthesis plates covered with bacterial biofilm and pre-incubated with [<sup>18</sup>F]PQ-VE1-vancomycin for PET imaging and/or vancomycin-IRDye800CW for optical imaging were fixed to post-mortem human tibiae and femora. PET/CT and fluorescence imaging were used to quantify the bacterial load before and after surgical debridement. Pre-debridement, PET imaging showed a significant 2.2-fold higher tracer uptake on biofilm-covered plates compared to plates without biofilm (p < 0.001). Post-debridement, the PET signal was marginal, demonstrating effective biofilm removal. Fluorescence-guided surgery enabled real-time visualization and removal of bacterial biofilms. Combined preoperative PET and intraoperative fluorescence imaging with vancomycin-based tracers allows noninvasive detection and real-time infection management, as demonstrated by these preliminary findings.

Medical subject headings